Biodesix (BDSX) 10% Owner Jack W. Schuler Buys 27,600 Shares

What Happened
Jack W. Schuler, a reported 10% owner of Biodesix, purchased a total of 27,600 Biodesix (BDSX) shares in two open‑market transactions: 13,900 shares on 2026-08-10 at a reported weighted average price of $24.25 (aggregate $337,029) and 13,700 shares on 2026-08-11 at a reported weighted average price of $24.01 (aggregate $328,911). Combined purchase value was $665,940, for an approximate overall price of $24.12 per share. These were purchases (which some investors view as a bullish signal), not sales.

Key Details

• Transaction dates: 2026-08-10 (13,900 shares) and 2026-08-11 (13,700 shares). Report filed 2026-08-12 (appears timely under Form 4 rules).
• Reported prices: $24.25 (Aug 10) and $24.01 (Aug 11); filing footnotes state the actual buys occurred across price ranges: $23.89–$24.50 (F1) and $23.965–$24.32 (F4). The filing lists weighted-average prices.
• Total shares acquired: 27,600; total reported consideration: $665,940; approximate weighted-average price ≈ $24.12/share.
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Notable footnotes: F2 explains adjustments to reported amounts due to transfers among related trusts (Jack W. Schuler Living Trust and the Jack W. Schuler 2026 GRAT) that were exempt under Rule 16a‑13; F3 and F5 note Schuler is sole trustee of the named trusts. The purchases themselves were open‑market (code P).

Context

• These were straightforward open‑market purchases by a 10% owner (an important insider category but distinct from employee/executive trades). Footnotes about trust transfers concern prior, exempt internal transfers and are not market trades.
• As with all insider buys, this is factual evidence of the insider increasing holdings but does not prove motive or future performance.